Technology_Biocytogen Pharmaceuticals (Beijing) Co., Ltd._Biocytogen, drug development, antibody discovery

Please input keywords

Database

Family Website

Eucure Biopharma

Biocytogen Boston Corp.

Social Responsibility

Join us

Partnerships

Pipeline

RenMice™ HiTS Platform

Technology

Antibody discovery platforms

Technologies

Unlocking competitive edge through integrated innovation

Bispecific Antibody Platform

RenLite common light-chain mouse platform, bispecific antibody assembly platform, and streamlined discovery process

Bispecific ADC Platform

Streamlined RenLite-based bsADC discovery process for 200+ TAA

TCR-Mimic Antibody Platform

TCRm antibodies for intracellular targets

GPCR Technology Platform

GPCR antibody discovery and screening supported by target knockout RenMice and target humanized mice.

Step 1

Antibody Discovery

Fully human antibody discovery...

Leveraging our proprietary fully human antibody mice, including RenMice (RenMab, RenLite, and RenNan...

Step 2

Preclinical Research

Preclinical Pharmacology Evalu...

We design robust in vivo and in vitro study models to evaluate the efficacy and safety of candidate...

Step 3

Translational Research

Large Animal Translational Res...

In comparison to implanted mouse tumor models, spontaneous tumors in larger animals, especially cani...

Step 4

Clinical Development

The Eucure clinical development team is highly experienced in drug development both domestically and...